Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Edaravone for Acute Ischemic Stroke
NCT04984577Phase 2Suspended
- Sponsor
- Nanjing Yoko Biomedical Co., Ltd.
- Start
- Nov 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edaravone, taurine in ischemic stroke, sponsored by Nanjing Yoko Biomedical Co., Ltd.. Started Nov 2021; status: suspended.
02
Drugs
edaravonetaurine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04984577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04984577.